| MolName | (5Z)-5-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C23H27N5O4S2 |
| Smiles | OCCN(CC1)CCN1C(N=C1N2C=CC=C1)=C(/C=C(/C(N1CC3OCCC3)=O)\SC1=S)C2=O |
| InChI | InChI=1S/C23H27N5O4S2/c29-12-11-25-7-9-26(10-8-25)20-17(21(30)27-6-2-1-5-19(27)24-20)14-18-22(31)28(23(33)34-18)15-16-4-3-13-32-16/h1-2,5-6,14,16,29H,3-4,7-13,15H2/t16-/m1/s1 |
| InChIK | DKNZUNQWWRARKV-MRXNPFEDSA-N |
| TotalMolweight | 501.63 |
| Molweight | 501.63 |
| MonoisotopicMass | 501.150445 |
| CLogP | -0.6109 |
| CLogS | -3.137 |
| H Acceptors | 9 |
| H Donors | 1 |
| TotalSurfaceArea | 362.95 |
| Relative PSA | 0.33167 |
| PolarSurfaceArea | 146.31 |
| Druglikeness | 7.2995 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 34 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Sp3Atoms | 16 |
| Symmetricatoms | 2 |
| Amides | 2 |
| Amines | 1 |
| AlkylAmines | 1 |
| BasicNitrogens | 2 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-5-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-5-[[2-[4-(2-hydroxyethyl)piperazin-1-yl]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one